Max Horowitz
YOU?
Author Swipe
View article: Activating the immune system is essential for the efficacy of heated intraperitoneal cisplatin in a murine model of advanced epithelial ovarian cancer (008)
Activating the immune system is essential for the efficacy of heated intraperitoneal cisplatin in a murine model of advanced epithelial ovarian cancer (008) Open
View article: Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer Open
OBJECTIVE (S): To evaluate travel distance in women with advanced or recurrent epithelial ovarian cancer (OC) undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and the subsequent impact upon outcomes. …
View article: Activation of Adaptive Immune Cells is an Early Response to Hyperthermic Intraperitoneal Chemotherapy Treatment in Ovarian Cancer
Activation of Adaptive Immune Cells is an Early Response to Hyperthermic Intraperitoneal Chemotherapy Treatment in Ovarian Cancer Open
Hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly increased the survival of epithelial ovarian (EOC) patients and is being adopted as a standard clinical approach for managing these tumors. However, while the clinical res…
View article: Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry Open
View article: A Novel Non-Invasive Epithelial Ovarian Cancer Mouse Model Of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
A Novel Non-Invasive Epithelial Ovarian Cancer Mouse Model Of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Open
Background Hyperthermic intraperitoneal chemotherapy (HIPEC) in combination with interval cytoreductive surgery increases the overall survival of epithelial ovarian cancer (EOC) patients with advanced disease. Despite its proven benefits, …
View article: Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer Open
View article: Single-Cell Analysis of Hyperthermic Intraperitoneal Chemotherapy Treated Tumors Reveals Distinct Cellular and Molecular Responses
Single-Cell Analysis of Hyperthermic Intraperitoneal Chemotherapy Treated Tumors Reveals Distinct Cellular and Molecular Responses Open
Summary Hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a clinical regimen that prolongs overall survival for patients with advanced Epithelial Ovarian Cancer (EOC). However, the mechanism of action of HIPEC remains poorly…
View article: Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity
Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity Open
Epithelial ovarian cancer (EOC) is a leading cause of cancer death in women. Standard of care treatment has remained platinum-containing cytotoxic chemotherapy for over three decades. Among the central challenges in treating ovarian CA are…
View article: Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer Open
View article: Table of Contents
Table of Contents Open
View article: Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer
Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer Open
View article: shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model Open
Multiple convergent lines of evidence implicate both α-synuclein (encoded by SCNA) and mitochondrial dysfunction in the pathogenesis of sporadic Parkinsonâs disease (PD). Occupational exposure to the mitochondrial complex I inhibitor ro…